Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor
Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor
复制标题
DOI:
10.1097/tp.0b013e31817ef6c9
复制
发表时间:
2008-07-27
期刊:
影响因子:
6.2
通讯作者:
Mullen, Yoko
中科院分区:
文献类型:
--
作者:
Ito, Tathei;Omori, Keiko;Mullen, Yoko
Background. The activation of p38 mitogen-activated protein kinases (MAPK) is implicated in cold ischemia-reperfusion injury of donor organs. The islet isolation process, from pancreas procurement through islet collection, may activate p38MAPK leading to cytokine release and islet damage. This damage may be prevented by treating pancreata with a p38MAPK inhibitor (p381H) before cold preservation.Methods. Pancreata removed from Beagle dogs were infused with University of Wisconsin solution containing the p38IH, SB203580, and Pefabloc (n=6) or vehicle (dimethyl sulfoxide and Pefabloc) alone (n=7), through the pancreatic duct and preserved using the two-layer method. After 20 to 22 hr, islets were isolated and 3000 IEQ/kg were autotransplanted into the corresponding dog to monitor glucose metabolism.Results. p38IH-treated pancreata yielded significantly more islets than control pancreata (IEQ/g: 2134 +/- 297 vs. 1477 +/- 145 IEQ/g or 65,012 +/- 9385 vs. 45,700 +/- 5103 IEQ/pancreas; P